Literature DB >> 20855517

Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae.

Merit Melin1, Krzysztof Trzciński, Martin Antonio, Seppo Meri, Richard Adegbola, Tarja Kaijalainen, Helena Käyhty, Merja Väkeväinen.   

Abstract

The polysaccharide capsule is a major virulence factor of Streptococcus pneumoniae; it affects complement resistance and shields the bacterium from phagocytes. Certain capsular serotypes appear to be better able to cause invasive disease than others. Serotypes 1 and 5 are common causes of invasive disease but are rarely isolated from healthy carriers, whereas serotypes 6B and 23F are more frequently isolated from carriage than invasive disease. We have recently shown that serotypes 6B and 19F differ in resistance to complement C3 deposition and opsonophagocytic killing. In this study we assessed the complement resistance and susceptibility to opsonophagocytosis of several other serotypes targeted by the pneumococcal conjugate vaccines. Clinical isolates of serotypes 1, 4, 5, 14, 18C, and 23F were tested along reference strains of corresponding capsular types. The concentration of anticapsular antibodies required for opsonophagocytic killing correlated inversely with C3 deposition on the serotype. Serotype 1 was the most resistant of the clinical isolates to C3 deposition and, along with serotypes 5 and 19F, required the highest concentration of capsule antibodies for opsonophagocytic killing, whereas serotype 23F was the most sensitive to opsonophagocytosis. Sensitivity to C3 deposition and opsonophagocytosis was associated with serotype-specific mortality of invasive pneumococcal disease, suggesting that the primary pathogens, such as serotypes 1 and 5, are more resistant to complement and require a higher concentration of capsule antibodies for opsonophagocytic killing than the opportunistic serotypes such as 6B and 23F, which are associated with a more severe disease outcome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855517      PMCID: PMC2981318          DOI: 10.1128/IAI.00739-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel.

Authors:  N Porat; R Trefler; R Dagan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.

Authors:  T Wuorimaa; R Dagan; M Väkeväinen; F Bailleux; R Haikala; M Yaich; J Eskola; H Käyhty
Journal:  J Infect Dis       Date:  2001-09-25       Impact factor: 5.226

3.  Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central Tennessee.

Authors:  D A Robinson; K M Edwards; K B Waites; D E Briles; M J Crain; S K Hollingshead
Journal:  J Infect Dis       Date:  2001-04-17       Impact factor: 5.226

4.  Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.

Authors:  R Malley; M Lipsitch; A Stack; R Saladino; G Fleisher; S Pelton; C Thompson; D Briles; P Anderson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

Authors:  W P Hausdorff; J Bryant; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

6.  Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.

Authors:  T Kilpi; E Herva; T Kaijalainen; R Syrjänen; A K Takala
Journal:  Pediatr Infect Dis J       Date:  2001-07       Impact factor: 2.129

7.  PspC, a pneumococcal surface protein, binds human factor H.

Authors:  S Dave; A Brooks-Walter; M K Pangburn; L S McDaniel
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

8.  Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies.

Authors:  Robert L Burton; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2006-09

9.  Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function.

Authors:  R Janulczyk; F Iannelli; A G Sjoholm; G Pozzi; L Bjorck
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

10.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Authors:  J Eskola; T Kilpi; A Palmu; J Jokinen; J Haapakoski; E Herva; A Takala; H Käyhty; P Karma; R Kohberger; G Siber; P H Mäkelä
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

View more
  22 in total

Review 1.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

2.  RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies.

Authors:  Carole Harfouche; Sara Filippini; Claudia Gianfaldoni; Paolo Ruggiero; Monica Moschioni; Silvia Maccari; Laura Pancotto; Letizia Arcidiacono; Bruno Galletti; Stefano Censini; Elena Mori; Marzia Giuliani; Claudia Facciotti; Elena Cartocci; Silvana Savino; Francesco Doro; Michele Pallaoro; Salvatore Nocadello; Giuseppe Mancuso; Mitch Haston; David Goldblatt; Michèle A Barocchi; Mariagrazia Pizza; Rino Rappuoli; Vega Masignani
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

3.  The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement.

Authors:  Merit Melin; Krzysztof Trzciński; Seppo Meri; Helena Käyhty; Merja Väkeväinen
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

4.  Mucin 1 protects against severe Streptococcus pneumoniae infection.

Authors:  Poshmaal Dhar; Garrett Z Ng; Eileen M Dunne; Philip Sutton
Journal:  Virulence       Date:  2017-07-13       Impact factor: 5.882

5.  Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement Evasion.

Authors:  Erika van der Maten; Bryan van den Broek; Marien I de Jonge; Kim J W Rensen; Marc J Eleveld; Aldert L Zomer; Amelieke J H Cremers; Gerben Ferwerda; Ronald de Groot; Jeroen D Langereis; Michiel van der Flier
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

6.  Specific Lipopolysaccharide Serotypes Induce Differential Maternal and Neonatal Inflammatory Responses in a Murine Model of Preterm Labor.

Authors:  Roberta Migale; Bronwen R Herbert; Yun S Lee; Lynne Sykes; Simon N Waddington; Donald Peebles; Henrik Hagberg; Mark R Johnson; Phillip R Bennett; David A MacIntyre
Journal:  Am J Pathol       Date:  2015-07-26       Impact factor: 4.307

7.  An ahemolytic pneumolysin of Streptococcus pneumoniae manipulates human innate and CD4⁺ T-cell responses and reduces resistance to colonization in mice in a serotype-independent manner.

Authors:  M Nadeem Khan; John Robert Coleman; Joshua Vernatter; Avanish Kumar Varshney; Chad Dufaud; Liise-Anne Pirofski
Journal:  J Infect Dis       Date:  2014-06-13       Impact factor: 5.226

Review 8.  Current concepts in host-microbe interaction leading to pneumococcal pneumonia.

Authors:  Joshua Vernatter; Liise-anne Pirofski
Journal:  Curr Opin Infect Dis       Date:  2013-06       Impact factor: 4.915

9.  The Pneumococcal Surface Proteins PspA and PspC Sequester Host C4-Binding Protein To Inactivate Complement C4b on the Bacterial Surface.

Authors:  Kashif S Haleem; Youssif M Ali; Hasan Yesilkaya; Thomas Kohler; Sven Hammerschmidt; Peter W Andrew; Wilhelm J Schwaeble; Nicholas J Lynch
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

10.  Comparative phylogenomics of Streptococcus pneumoniae isolated from invasive disease and nasopharyngeal carriage from West Africans.

Authors:  Eric S Donkor; Richard A Stabler; Jason Hinds; Richard A Adegbola; Martin Antonio; Brendan W Wren
Journal:  BMC Genomics       Date:  2012-10-29       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.